Fortfahren mit
Größe auswählen
| Größe/SKU | Verfügbarkeit | Preis |
|---|---|---|
30 mg | Warenkorb auf Verfügbarkeit prüfen | € 1.270,00 |
Über diesen Artikel
grade
pharmaceutical primary standard
agency
USP
API family
levalbuterol
manufacturer/tradename
USP
application(s)
pharmaceutical
pharmaceutical (small molecule)
format
neat
SMILES string
N(C(C)(C)C)CC(O)c1cc(c(cc1)O)COC
InChI
1S/C14H23NO3/c1-14(2,3)15-8-13(17)10-5-6-12(16)11(7-10)9-18-4/h5-7,13,15-17H,8-9H2,1-4H3
InChI key
AWYDXHUMBDRXQO-UHFFFAOYSA-N
General description
For further information and support please go to the website of the issuing Pharmacopoeia.
Application
Also, for use with USP monographs such as:
- Levalbuterol Hydrochloride
- Levalbuterol Inhalation Solution
- Albuterol Tablets
- Albuterol Extended-Release Tablets
Analysis Note
Other Notes
1 of 1
Dieser Artikel | |||
|---|---|---|---|
| description United States Pharmacopeia (USP) Reference Standard | description United States Pharmacopeia (USP) Reference Standard | description United States Pharmacopeia (USP) Reference Standard | description United States Pharmacopeia (USP) Reference Standard |
| grade pharmaceutical primary standard | grade pharmaceutical primary standard | grade pharmaceutical primary standard | grade pharmaceutical primary standard |
| manufacturer/tradename USP | manufacturer/tradename USP | manufacturer/tradename USP | manufacturer/tradename USP |
| format neat | format neat | format neat | format neat |
| application(s) pharmaceutical (small molecule) | application(s) pharmaceutical (small molecule) | application(s) pharmaceutical (small molecule) | application(s) pharmaceutical (small molecule) |
| API family levalbuterol | API family levalbuterol | API family levalbuterol | API family levalbuterol |
| agency USP | agency USP | agency USP | agency USP |
Lagerklasse
11 - Combustible Solids
Was ist los?
WGK 3
Hier finden Sie alle aktuellen Versionen:
Besitzen Sie dieses Produkt bereits?
In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.
